Characterization and Stabilization of a New (64)Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography

Early diagnosis of pancreatic cancer using current imaging modalities remains challenging. We have developed a new approach to identify tumor lesions ≥ 3 mm in the pancreas by positron emission tomography (PET) with a new intraperitoneally administered (64)Cu-labeled anti-epidermal growth factor rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hiroki, Igarashi, Chika, Tachibana, Tomoko, Hihara, Fukiko, Waki, Atsuo, Zhang, Ming-Rong, Yoshida, Sei, Naito, Kenichiro, Kurihara, Hiroaki, Ueno, Makoto, Ito, Kimiteru, Higashi, Tatsuya, Yoshii, Yukie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779674/
https://www.ncbi.nlm.nih.gov/pubmed/35056963
http://dx.doi.org/10.3390/pharmaceutics14010067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779674/
https://www.ncbi.nlm.nih.gov/pubmed/35056963
http://dx.doi.org/10.3390/pharmaceutics14010067

Ejemplares similares